Kaerus Bioscience's KER-0193 Achieves FDA Orphan Drug and Rare Pediatric Designations for Fragile X Syndrome #United_States #London #Fragile_X_Syndrome #Kaerus_Bioscience #KER-0193
0
0
0
0
Kaerus Bioscience's KER-0193 Achieves FDA Orphan Drug and Rare Pediatric Designations for Fragile X Syndrome #United_States #London #Fragile_X_Syndrome #Kaerus_Bioscience #KER-0193